Recent developments with Design Therapeutics Inc (DSGN) have led to the company’s beta value being reach 1.84 cents.
Design Therapeutics Inc (NASDAQ: DSGN) on Friday, soared 4.34% from the previous trading day, before settling in for the closing price of $5.99. Within the